Skip to content

Dear colleagues,

In closing the year 2019 with Menopause Live, I would like to thank all those of you who have contributed expert commentaries on relevant research in the field of menopausal medicine and women’s midlife health. This year Menopause Live has issued 45 bulletins. I feel extremely privileged to be the means through which this has happened.

The practice of menopausal medicine is not easy as it not only deals with an important physical and psychological transition for women but also with the implications and the complications of aging. Moreover, the use of hormones to relieve menopausal symptoms is still a continuous matter of debate. The goal of Menopause Live is to keep scholars, researchers, and practitioners abreast of the relevant new research findings, especially those with a possible impact on daily practice.

I would like to highlight the continued effort of the IMS Board in delivering clinically relevant messages to this regard and putting research data into perspective through Menopause Live. In 2019 you may have valued reading the following expert statements:

A new publication in BMJ linking Alzheimer’s Disease to menopausal hormone therapy use, comment on “Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study” by Hanna Savolainen-Peltonen, et al.

International Menopause Society Consensus Statement on Testosterone Treatment for Women: Key Messages, comment on “Global Consensus Position Statement on the Use of Testosterone Therapy for Women” by Davis SR, et al.

The International Menopause Society comment on “Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.” by Collaborative Group on Hormonal Factors in Breast Cancer

Menopause Live needs the continued sustenance from the IMS members, each with his/her own personal experience and expertise. This is why I would like to invite you to share your insights with your fellows through evidence-based commentaries, on the research that is published in menopausal medicine.

Menopause Live is also trying to launch a case report series. I would like to encourage the contribution of high-quality case reports on your behalf, relating to diverse disciplines, including gynecological, endocrinological, metabolic, cardiovascular, bone, neurological, psychiatric postreproductive health. This last November 11th you may have enjoyed reading our pilot case report on MHT and Systemic Lupus Erythematosus, very much appreciated especially by the clinicians.

You may contact me directly at

May 2020 may be filled with good health and great personal and professional achievements for all of you.


  • Patrizia Monteleone
    Scientific Editor for Menopause Live


International Menopause Society

Install International Menopause Society - DEV

Install this application on your home screen for quick and easy access when you’re on the go.

Just tap then “Add to Home Screen”